SCORPIUS HOLDINGS, INC.

Profile

Company Names

SCORPIUS HOLDINGS, INC.
HEAT BIOLOGICS, INC.

Addresses

627 DAVIS DRIVE, SUITE 300, MORRISVILLE, NC 27560

801 CAPITOLA DRIVE, DURHAM, NC 27713

100 EUROPA DRIVE, SUTE 420, CHAPEL HILL, NC 27517

100 EUROPA DRIVE, SUITE 420, CHAPEL HILL, NC 27517

ATLANTIC CENTER, 119 WASHINGTON AVENUE, SUITE 401, MIAMI BEACH, FL 33139

Phone Numbers

919-240-7133
305-432-4684

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$23,617,932.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2025-02-12 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
6
2025-01-30 
$600,000.00 
$600,000.00 
$0.00 
Debt 
5
2024-12-06 
$13,388,889.00 
$13,388,889.00 
$0.00 
Debt 
4
2017-04-28 
$500,000.00 
$500,000.00 
$0.00 
Equity 
3
2013-03-25 
$5,050,050.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2011-12-20 
$2,829,243.00 
$4,137,487.00 
$1,308,244.00 
Equity 
1
2009-11-03 
$249,750.00 
$249,750.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
BELSKY 
DIRECTOR
PAUL 
MARC 
BELSKY 
DIRECTOR
VADIM 
 
DEYEV 
EXECUTIVE OFFICER
JENNIFER 
LYNN 
HARRIS 
EXECUTIVE OFFICER
JEFFREY 
 
HUTCHINS 
EXECUTIVE OFFICER
SCOTT 
 
KATZMAN 
DIRECTOR
JOHN 
JAMES 
MONAHAN 
DIRECTOR
WILLIAM 
 
OSTRANDER 
EXECUTIVE OFFICER
JOHN 
 
PRENDERGAST 
DIRECTOR
JOHN 
K.A. 
PRENDERGAST 
DIRECTOR
ANN 
 
ROSAR 
EXECUTIVE OFFICER
SANDRA 
LETA 
SILBERMAN 
EXECUTIVE OFFICER
EDWARD 
BYRON 
SMITH, III 
DIRECTOR
TAFFY 
 
WILLIAMS 
EXECUTIVE OFFICER
JEFF 
 
WOLF 
EXECUTIVE OFFICER, DIRECTOR
JEFFREY 
 
WOLF 
EXECUTIVE OFFICER, DIRECTOR
JEFFREY 
ALAN 
WOLF 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-02-12 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-01-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2024-12-06 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-04-28 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-03-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
THINKEQUITY LLC